Beijing Minhai Biotechnology Co., Ltd.

Develops and manufactures human vaccines. It reports nine marketed products, among them a quadrivalent DTaP-Hib combination vaccine, a 13-valent pneumococcal conjugate vaccine with dual carrier proteins, a freeze-dried human diploid cell rabies vaccine and a live attenuated varicella vaccine, with close to thirty more in development. Founded in 2004 in Beijing's Daxing district.